Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension

被引:86
|
作者
Dewachter, Laurence
Adnot, Serge
Fadel, Elie
Humbert, Marc
Maitre, Bernard
Barlier-Mur, Anne-Marie
Simonneau, Gerald
Hamon, Michel
Naeije, Robert
Eddahibi, Saadia
机构
[1] Hop Henri Mondor, AP HP, Dept Physiol, F-94010 Creteil, France
[2] Hop Marie Lannelongue, Serv Chirurgie Thorac Vasc & Transplant Cardiopul, UPRES EA 2705, F-92350 Le Plessis Robinson, France
[3] Hop Antoine Beclere, AP HP, Serv Pneumol, Clamart, France
[4] Univ Paris 06, INSERM, Fac Med Pitie Salpetriere, UMR 677, Paris, France
[5] Free Univ Brussels, Fac Med, Physiol Lab, Brussels, Belgium
关键词
angiopoietin-1; growth factors; idiopathic pulmonary arterial hypertension; pulmonary artery smooth muscle; pulmonary endothelial cells;
D O I
10.1164/rccm.200602-304OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Angiopoietins are involved in blood vessel maturation and remodeling. Objectives: One consequence of endothelium-specific tyrosine kinase-2 (Tie2) receptor activation by angiopoietin-1 (Ang1) is the release of endothelium-derived growth factors that recruit vascular wall cells. We investigated this process in idiopathic pulmonary arterial hypertension (iPAH). Methods: Ang1, Ang2, and total and phosphorylated Tie2 expression (mRNA and protein) was evaluated in human lung specimens and in cultured pulmonary artery smooth muscle cells (PA-SMCs) and pulmonary endothelial cells (P-ECs) isolated from patients with iPAH and control subjects. Media collected from Ang1-treated P-ECs were assessed for their PA-SMC growth-promoting effect. Measurements and Main Results: Tie2 receptor was fourfold higher in lungs and P-ECs from patients with iPAH than in those from control subjects, with a parallel increase in phosphorylated lung Tie2 receptor. In contrast, Ang1 and Ang2 expression in lungs, P-ECs, and PA-SMCs did not differ. Incubation of PA-SMCs with medium collected from P-EC cultures induced marked proliferation, and this effect was stronger when using P-ECs from patients with iPAH than from control subjects. Ang1 pretreatment of P-ECs from either patients or control subjects induced a further increase in PA-SMC proliferation. Fluoxetine, an inhibitor of the mitogenic action of serotonin, reduced the growth-promoting effect of P-EC media. Ang1 added to P-ECs from patients with iPAH increased the production of endothelin-1 (ET-1) and serotonin, but not of plateletderived growth factor-BB orepidermal growth factor, and increased the amount of mRNA encoding tryptophan hydroxylase-1 (the rate-limiting enzyme of serotonin synthesis), preproET-1, and ET-11-converting enzyme. Conclusions: The Ang1/Tie2 pathway is potentiated in iPAH, contributing to PA-SMC hyperplasia via increased stimulation of endothelium-derived growth factors synthesis by P-ECs.
引用
收藏
页码:1025 / 1033
页数:9
相关论文
共 50 条
  • [31] Targeting the ANGPT–TIE2 pathway in malignancy
    Hanhua Huang
    Abhijit Bhat
    Gary Woodnutt
    Rodney Lappe
    Nature Reviews Cancer, 2010, 10 : 575 - 585
  • [32] Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling
    Mueller, Sarah B.
    Kontos, Christopher D.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09): : 3188 - 3191
  • [33] Cholesterol depletion of endothelial cell plasma membranes hyperactivates the angiopoietin-1/Tie2 signaling pathway
    Zöllner, S
    Gratton, JP
    Fulton, D
    Fontana, JT
    Sessa, WC
    CIRCULATION, 2001, 104 (17) : 300 - 300
  • [34] Association study between of Tie2/Angiopoietin-2 and VEGF/KDR pathway gene polymorphisms and vascular malformations
    Zheng, Qiupeng
    Du, Jing
    Zhang, Zhaofeng
    Xu, Jianhua
    Fu, Lingyuan
    Cao, Yunlei
    Huang, Xianliang
    Guo, Lingli
    GENE, 2013, 523 (02) : 195 - 198
  • [35] EXPRESSION AND CLINICAL SIGNIFICANCE OF THE ANGIOPOIETIN-1, ANGIOPOIETIN-2 AND TIE2 IN COLORECTAL CANCER.
    Baek, M.
    Cho, S.
    Ahn, T.
    DISEASES OF THE COLON & RECTUM, 2011, 54 (05) : E166 - E166
  • [36] Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
    Lepetit, H
    Eddahibi, S
    Fadel, E
    Frisdal, E
    Munaut, C
    Noel, A
    Humbert, M
    Adnot, S
    D'Ortho, MP
    Lafuma, C
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (05) : 834 - 842
  • [37] Regulation of Angiopoietin Signalling by Soluble Tie2 Ectodomain and Engineered Ligand Trap
    Deborah O. A. Alawo
    Tariq A. Tahir
    Marlies Fischer
    Declan G. Bates
    Svetlana R. Amirova
    Nicholas P. J. Brindle
    Scientific Reports, 7
  • [38] Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
    Felcht, Moritz
    Luck, Robert
    Schering, Alexander
    Seidel, Philipp
    Srivastava, Kshitij
    Hu, Junhao
    Bartol, Arne
    Kienast, Yvonne
    Vettel, Christiane
    Loos, Elias K.
    Kutschera, Simone
    Bartels, Susanne
    Appak, Sila
    Besemfelder, Eva
    Terhardt, Dorothee
    Chavakis, Emmanouil
    Wieland, Thomas
    Klein, Christian
    Thomas, Markus
    Uemura, Akiyoshi
    Goerdt, Sergij
    Augustin, Hellmut G.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (06): : 1991 - 2005
  • [39] Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2
    Kim, KT
    Choi, HH
    Steinmetz, MO
    Maco, B
    Kammerer, RA
    Ahn, SY
    Kim, HZ
    Lee, GM
    Koh, GY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) : 20126 - 20131
  • [40] Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma
    Chen, Libo
    Yang, Zhen
    Wang, Guobin
    Wang, Chunyou
    Journal of Huazhong University of Science and Technology - Medical Science, 2001, 21 (03): : 228 - 230